These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 16002176

  • 1. C-reactive protein is elevated in obese patients with the metabolic syndrome.
    Florez H, Castillo-Florez S, Mendez A, Casanova-Romero P, Larreal-Urdaneta C, Lee D, Goldberg R.
    Diabetes Res Clin Pract; 2006 Jan; 71(1):92-100. PubMed ID: 16002176
    [Abstract] [Full Text] [Related]

  • 2. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K, Konturek SJ, Sodowski M, Wylezol M, Kuka D, Sowa P, Adamczyk-Sowa M, Kukla M, Berdowska A, Rehfeld JF, Bielanski W, Brzozowski T.
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
    [Abstract] [Full Text] [Related]

  • 3. Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin.
    González AS, Guerrero DB, Soto MB, Díaz SP, Martinez-Olmos M, Vidal O.
    Eur J Clin Nutr; 2006 Jun; 60(6):802-9. PubMed ID: 16493453
    [Abstract] [Full Text] [Related]

  • 4. Does C-reactive protein identify a subclinical metabolic disease in healthy subjects?
    Bo S, Gambino R, Uberti B, Mangiameli MP, Colosso G, Repetti E, Gentile L, Cassader M, Pagano GF.
    Eur J Clin Invest; 2005 Apr; 35(4):265-70. PubMed ID: 15816996
    [Abstract] [Full Text] [Related]

  • 5. Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome.
    Santos AC, Lopes C, Guimarães JT, Barros H.
    Int J Obes (Lond); 2005 Dec; 29(12):1452-6. PubMed ID: 16077717
    [Abstract] [Full Text] [Related]

  • 6. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.
    Onat A, Hergenç G, Türkmen S, Yazici M, Sari I, Can G.
    Metabolism; 2006 Apr; 55(4):445-52. PubMed ID: 16546474
    [Abstract] [Full Text] [Related]

  • 7. Insulin resistance is associated with C-reactive protein independent of abdominal obesity in nondiabetic Taiwanese.
    Chou HH, Hsu LA, Liu CJ, Teng MS, Wu S, Ko YL.
    Metabolism; 2010 Jun; 59(6):824-30. PubMed ID: 20004425
    [Abstract] [Full Text] [Related]

  • 8. C-reactive protein and features of metabolic syndrome in Brazilian women with previous gestational diabetes.
    Ferraz TB, Motta RS, Ferraz CL, Capibaribe DM, Forti AC, Chacra AR.
    Diabetes Res Clin Pract; 2007 Oct; 78(1):23-9. PubMed ID: 17449131
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular risk factors in obese women and their first-degree relatives.
    Saraç F, Ozgen AG, Yilmaz C, Tüzün M.
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):371-7. PubMed ID: 18065331
    [Abstract] [Full Text] [Related]

  • 10. The association of low-grade inflammation, urinary albumin, and insulin resistance with metabolic syndrome in nondiabetic Taiwanese.
    Lee IT, Lee WJ, Huang CN, H-H Sheu W.
    Metabolism; 2007 Dec; 56(12):1708-13. PubMed ID: 17998025
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A.
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [Abstract] [Full Text] [Related]

  • 12. Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome.
    Dupuy AM, Jaussent I, Lacroux A, Durant R, Cristol JP, Delcourt C.
    Gerontology; 2007 Jan; 53(6):329-39. PubMed ID: 17551260
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
    Mojiminiyi OA, Abdella NA, Al Arouj M, Ben Nakhi A.
    Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
    [Abstract] [Full Text] [Related]

  • 16. Alanine aminotransferase and high sensitivity C-reactive protein: correlates of cardiovascular risk factors in youth.
    Oliveira AC, Oliveira AM, Almeida MS, Silva AM, Adan L, Ladeia AM.
    J Pediatr; 2008 Mar; 152(3):337-42. PubMed ID: 18280837
    [Abstract] [Full Text] [Related]

  • 17. Waist circumference is the main determinant of elevated C-reactive protein in metabolic syndrome.
    Nakamura H, Ito H, Egami Y, Kaji Y, Maruyama T, Koike G, Jingu S, Harada M.
    Diabetes Res Clin Pract; 2008 Feb; 79(2):330-6. PubMed ID: 17964679
    [Abstract] [Full Text] [Related]

  • 18. Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein.
    Hung YJ, Lin SH, Pei D, Kuo SW, Hsieh CH, He CT, Hsing Lee C, Fan SC, Sheu WH.
    Metabolism; 2006 Apr; 55(4):439-44. PubMed ID: 16546473
    [Abstract] [Full Text] [Related]

  • 19. C-reactive protein and metabolic syndrome in women with previous gestational diabetes.
    Di Cianni G, Lencioni C, Volpe L, Ghio A, Cuccuru I, Pellegrini G, Benzi L, Miccoli R, Del Prato S.
    Diabetes Metab Res Rev; 2007 Feb; 23(2):135-40. PubMed ID: 16770838
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.